Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
Summary generated by The Flow from the publisher's feed. The full article lives at DeepMind Blog.
Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.
Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Biologists use Co-Scientist to find novel factors that successfully rejuvenate human cells.
arXiv:2607. 02944v1 Announce Type: cross Abstract: We propose PRECEDE, a precedent-guided co-scientist for side-effect-aware drug redesign that revises a parent compound to mitigate a specified side effect while preserving therapeutic function.
Accelerating the development of life-saving treatments.
